This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Invention for Innovation - Connect Call 5 Stage 1 Minutes

Contents

Minutes of the Invention for Innovation (i4i) programme sub-committee meeting to discuss stage one applications (expression of interest) to i4i Connect call 5.

Date and location 

Meeting held on 28 September 2021 via Zoom Virtual Meeting

In attendance

Sub-Committee

Professor Paul Sibbons (Chair)

i4i Secretariat

Professor Mike Lewis (Programme Director)
Dr Ruth Nebauer (Assistant Director)
Dr Andrew Barber
Dr Silvana Cossins
Dr Sandra Nwokeoha
Dr Francesca Troiani
Mr Edwin Tucker

Operations

Miss Cordelia Davey Wright

Apologies

Dr Ian Newington
Dr Helen Compton

Stage 1 applications invited to submit stage 2 

NIHR203817: Delivering at-home access to clinical-standard fertility treatment
Outcome: Invite to Stage 2 

NIHR203823: Cardiac Rhythm Monitoring Smart Garment
Outcome:
Invite to Stage 2 

NIHR203824: The Research, Development and Useability Testing of an Alpha Prototype of the ‘Headway’ Digital Device Facilitating Family-based Self-help for the Mental Health of Children and Young People.
Outcome: Invite to Stage 2

NIHR203825: Informatics system for home-based digital gestational diabetes screening
Outcome: Invite to Stage 2 

NIHR203838: Mistral: an innovative device for mixing and delivering gas for use in vitreoretinal surgery
Outcome: Invite to Stage 2

NIHR203841: Pre-clinical development of a wound infection sensor
Outcome: Invite to Stage 2 

NIHR203843: Digital Histopathology Screening Platform - Transforming Breast Cancer Diagnosis
Outcome: Invite to Stage 2

NIHR203853: Development of a Rapid Point of Care Test to Identify CYP2C19 Genotype and Inform Antiplatelet Prescribing
Outcome: Invite to Stage 2

NIHR203855: The development of novel antimicrobial materials for use as additives and/or coatings within medical devices.
Outcome: Invite to Stage 2

NIHR203858: Infi-care System - smart textile system for detection, prevention and management of pressure ulcers.
Outcome: Invite to Stage 2 

NIHR203866: Zeus Home Trial - Study of transcutaneous electrical stimulation in obstructive sleep apnoea using the ZeusOSA device.
Outcome: Invite to Stage 2 

NIHR203868: Renovite - regenerative nanoclay for wound applications
Outcome: Invite to Stage 2 

NIHR203876: Post-Operative Ileus Sound-based Evaluation (POISE)
Outcome: Invite to Stage 2 

NIHR203887: Development and validation of prototype to treat chemotherapy induced alopecia
Outcome: Invite to Stage 2 

NIHR203870: Textile electrode cuff to enable FES-assisted walking for users with upper limb impairments
Outcome: Invite to Stage 2 

NIHR203872: Hands free-control of upper arm prostheses using The Earswitch, and translation to functional, active, assistive support (The Earswitch FAAS-brace) for upper-limb weakness post-stroke, cervical spinal cord injury and neuropathies.
Outcome: Invite to Stage 2

NIHR203888: Remote Monitoring Device for High-Risk Chronic Vascular Patients
Outcome: Invite to Stage 2 

NIHR203891: Tamer App: An AI-powered pain management app for adolescents with chronic pain
Outcome: Invite to Stage 2

NIHR203895: Advanced image registration for 1View – An augmented reality software platform for inter-operative guidance during Mechanical Thrombectomy (MT's) procedures - Giving Stroke victims a better chance
Outcome: Invite to Stage 2

NIHR203898: Developing a novel medical device to address chronic severe incontinence in men in order to improve patient care and healthcare outcomes
Outcome: Invite to Stage 2

NIHR203903: Next Generation Antibacterial Medical Devices
Outcome: Invite to Stage 2

NIHR203913: Measuring and releasing stress using a wearable ear piece
Outcome: Invite to Stage 2 

NIHR203914: Using Virtual Reality to scale MBCT practices to at risk working groups: A feasibility trial
Outcome: Invite to Stage 2 

NIHR203919: Modular, intelligent ventilation and anaesthesia platform for safer patient care
Outcome: Invite to Stage 2 

NIHR203927: Accessible Genomics: Clinical evaluation of a novel genomics platform to aid precision diagnosis and management of cardiovascular disease
Outcome: Invite to Stage 2 

NIHR203929: Smartphone Spirometry
Outcome: Invite to Stage 2 

NIHR203942: A next-generation cognitive orthotic and neurorehabilitation platform to improve service provision of community neurorehabilitation and provide long-term support to patients and caregivers.
Outcome: Invite to Stage 2

NIHR203944: Passive brain tumour visulisation during surgery using computer vision
Outcome: Invite to Stage 2 

Stage 1 applications that did not score highly enough to be considered for Stage 2

NIHR203736: Automated Urine Recording in the Acute setting (AURA): an innovative monitoring system for improving patient safety for catheterised patients in NHS hospitals.
Outcome: Reject

NIHR203822: Validation of assay to assess suscpetibility for cytokine storm in COVID-19.
Outcome: Reject

NIHR203826: Medication Adherence: Closing the Loop
Outcome: Reject

NIHR203829: Development of a Genomic Guided Personalised Dosing Tool for Docetaxel Treatment of Prostate Cancer
Outcome: Reject

NIHR203830: BCI Mediated Multi-Sensory Upper Body Rehabilitation System
Outcome: Reject

NIHR203835: “EAR-metrics” biometric sensors in the ear; Developing a handheld diagnostic tool, whilst validating continuous EAR-metrics monitoring from hearing-aids and earphones
Outcome: Reject

NIHR203836: Development of a triggerable dissolving ureteric stent.
Outcome: Reject

NIHR203837: Feasibility study to determine efficacy of a digital multimodal Prehabilitation programme including user and clinical engagement and move from waiting lists to surgical preparation lists.
Outcome: Reject

NIHR203839: Gait analyses and clinical efficacy study to develop a novel paediatric active assist splint (OrthoPed splint) and to collect the clinical data needed for regulatory compliance.
Outcome: Reject

NIHR203840: Research work conducted to develop COSMA - a treatment and ecosystem solution for dementia replacing the current dementia treatment pathway in the NHS
Outcome: Reject

NIHR203847: Development and study of the Walk-A-Cise app for patients with peripheral arterial disease
Outcome: Reject

NIHR203848: Development of low-cost system for monitoring usage of walking aids.
Outcome: Reject

NIHR203850: Portable Intermittent Pneumatic Compression (IPC) device with connectivity to provide remote monitoring of ambulation and control of the device.
Outcome: Reject

NIHR203852: Rebuilding skin from in the inside: Development of ProMatrix regenerative scaffold for accelerated, scarless skin reconstruction.
Outcome: Reject

NIHR203860: eScent reusable FFP3 mask with automatically delivered antiviral aerosol.
Outcome: Reject

NIHR203861: Safe IV- Development of a medical device to prevent the problem of accidental administration of residual anaesthetic drugs in IV access devices.
Outcome: Reject

NIHR203862: Facilitating the embedding of the Optishield optical occluder into the healthcare market, and developing an additional design aimed primarily at Neuro-ophthalmology.
Outcome: Reject

NIHR203863: Digital lifestyle and medicine-management solution for menopause which will significantly impact menopause-specific quality of life and deliver NHS efficiency savings
Outcome: Reject

NIHR203864: Validating novel Survey Pictorial Representation of Illness and Self Measure (SPRISM) for Chronic Renal and Itch
Outcome: Reject

NIHR203865: Development and certification of a low cost, point-of-care, exhaled breath condensate collector
Outcome: Reject

NIHR203869: A double-blind musculoskeletal telediagnostic sensitivity and specificity proof of concept study.
Outcome: Reject

NIHR203873: CareGO - A whole-system approach to the unmet needs of the endoscopy patient journey through digitalisation of patient pathways and improved delivery of healthcare consumable goods
Outcome: Reject

NIHR203874: Project WAiRD: Innovation in hospital-based telemetry for service improvement across the NHS.
Outcome: Reject

NIHR203875: Improving Patient Screening in Clinical Trials
Outcome: Reject

NIHR203879: EazyIV - Developing a Semi-Automatic Intravenous Cannula
Outcome: Reject

NIHR203881: BioSpy™: an AI system for histopathological diagnosis of small intestinal biopsies - transition from prototype to early clinical evaluation.
Outcome: Reject

NIHR203882: OSCAR: Development of the first end-to-end, intelligent medication control system
Outcome: Reject

NIHR203886: Interactive Paediatric Observation and Outcome Resource for ilL Young Children: the iPoorly project.
Outcome: Reject

NIHR203894: Feasibility assessment of Point-of-care Acute Kidney Injury test
Outcome: Reject

NIHR203896: Prostate Cancer Enhanced Risk stratification using Artificial Intelligence
Outcome: Reject

NIHR203897: POC Asthma: Point of care device to manage and diagnose asthma
Outcome: Reject

NIHR203900: Final development and placement on the market of Electrox Wound Cleanser.
Outcome: Reject

NIHR203905: Patient trail delivering interactive MSK digital self-care incorporating virtual clinical support, social media peer support & enhanced digital self-care resources via a smartphone app.
Outcome: Reject

NIHR203906: Rapid, cost-effective antimicrobial susceptibility testing to guide antibiotic prescriptions for hospitalised patients (RASTER)
Outcome: Reject

NIHR203910: An evaluation and validation study to prove efficacy of the midwife's palm device
Outcome: Reject

NIHR203911: Development of a new device, the Ductionometer, to quantify eye movement excursions in a clinical setting
Outcome: Reject

NIHR203912: Development of a DNA nanotechnology test for rapid detection of miR-122 as a biomarker of drug-induced liver injury in patients with suspected paracetamol overdose
Outcome: Reject

NIHR203915: PerDeCT (Pericardial Device to monitor Cardiac output and diagnose Tamponade) for cardiac surgery
Outcome: Reject

NIHR203917: Tackling healthcare acquired respiratory infections: an innovative oxygen mask reducing aerosol from breath and cough
Outcome: Reject

NIHR203920: Bone Regenerating 3D Printed Knee Implants: Keeping Osteoarthritis Patients Healthy & Active
Outcome: Reject

NIHR203921: Manual lung-protective ventilation to improve outcomes and decrease costs.
Outcome: Reject

NIHR203922: PPI exercise assessing the degree of unmet need, benefits, attitudes and co-design input with service users of using automatically transcribed session summaries to “bridge” between mental health therapy sessions.
Outcome: Reject

NIHR203924: Silent panels for intensive care
Outcome: Reject

NIHR203925: Certification of Careology as a Class II medical device, ensuring future advancements can be developed and deployed, to fulfil its potential in transforming traditional cancer care.
Outcome: Reject

NIHR203926: Digital GHOST RECON - Reconditioning pedalling bridge cycle Gluteal High Output Synchronised Training
Outcome: Reject

NIHR203930: Helping COPD patients navigate subjectivity with data
Outcome: Reject

NIHR203931: Novel integration of nanotech, medical devices and AI to create a rapid, non-invasive, instrument-free point-of-care diagnostic platform for infectious disease
Outcome: Reject

NIHR203932: The benefits of EktoTherix for Secondary Intention Wound Healing and Skin Grafting
Outcome: Reject

NIHR203933: Testing an exergaming holistic solution to support people living with dementia, keeping an active body and mind, while maintaining social connectivity and good wellbeing.
Outcome: Reject

NIHR203935: Remedy is a digital platform developed by Weatherden to fundamentally reconstruct how early clinical trials are performed by putting patients at the centre of clinical development.
Outcome: Reject

NIHR203936: Stix Mindfulness Activity Development
Outcome: Reject

NIHR203937: First of class medical device for diagnosis of cardiac arrest.
Outcome: Reject

NIHR203938: iNeuroCare
Outcome: Reject

NIHR203939: Autonomous Conversational Patient Reported Outcomes to Support Long-Term Clinical Monitoring
Outcome: Reject

NIHR203940: Point of care trans-dermal NMR blood analysis of transcriptional biomarkers in pre-symptomatic SARS-CoV-2 infections
Outcome: Reject

NIHR203941: A new future for Alzheimer’s Disease: Targeting Neuroinflammation for Expedited Medicine Approval
Outcome: Reject

NIHR203943: Unlocking potential of adaptive immunity in early cancer detection
Outcome: Reject

NIHR203849: CHARIBDIS Project : High-speed enumeration & CHARacterisation of viable CTCs Isolated from BlooD using high-efficiency Microfluidic VortIceS
Outcome: Reject